Frances Payne Bolton School of Nursing
Cleveland, Ohio, 44106, United States
NCT Number: NCT01304862
The purpose of this study is to determine whether mental health treatment disengagement may be mitigated by reducing barriers to self-management and enhancing self-management skills.
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Not applicable
Cleveland, Ohio, 44106, United States
Each year, more than four million young adults (age 18-25 years old) in the U.S. receive psychotropic medication or psychotherapy as treatment for a mental illness. One in every four of these young adults will disengage from mental health treatment before significant symptom remission is achieved. Mental health treatment disengagement may be mitigated by reducing barriers to self-management and enhancing self-management skills. Electronic self-management resource training for mental health (eSMART-MH) is an innovative use of avatars-virtual persons who tailor responses to users-to improve mental health treatment disengagement.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Involves simulated interactions between participants and the virtual health care providers (avatars).
20 minute screen-based educational videos on topics about healthy living--nutrition, physical activity, and sleep hygiene.
Time frame: 12 weeks
Medical Adherence Measure Medication Module (MAMMM) is a 7-item scale that will determine the patient's degree of engagement and initiation of mental health treatment.
Time frame: 12 weeks
A 6-item four point Likert type scale that asks participants to rate each item from 1 (strongly disagree) to 4 (strongly agree); a higher score indicates more mental illness stigma.
Time frame: 12 weeks
A 12-item scale that utilizes a 7-point Likert type scale with responses ranging from 1 (strongly disagree) to 7 (strongly agree). Total scores range from 12-84, with a higher score indicating higher mental health literacy.
Time frame: 12 weeks
13-item measure that assesses the patient's perception of their knowledge, skill, and confidence in self-management behavior. Scores range from 0-100, with a higher score indicating greater patient activation.
Time frame: 12 weeks
A 16-item five point Likert scale that asks participants to rate items from 5 (important) to 1 (unimportant); a higher score indicates greater perceived self-competence and effective communication with a health care provider.
Time frame: 12 weeks
A 14-item self-report measure that assesses anxiety and depression symptom severity. The HADS contains separate subscales (7 items each) for depression and anxiety; items are scored on a four point scale from 0-4, and a summative score is generated for each subscale. A cut score of 8 signifies an increased clinical risk for anxiety and depression.
Time frame: 12 weeks
To assess feasibility, the frequency of refusals and incidence of complete intervention doses will be documented. Acceptability will be assessed by utilizing and adapted acceptability scale administered at the final time point.
Case Western Reserve University
Other
Acronym: eSMART-MH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03674138
Anxiety, Anxiety Disorders
Tampa, Florida, United States
View Trial DetailsNCT03118752
Acute Coronary Syndrome, Anxiety Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT03925168
Anxiety, Anxiety Disorders
New Orleans, Louisiana, United States
View Trial DetailsNCT01482806
Anxiety Disorders, Behavior
Pittsburgh, Pennsylvania, United States
View Trial Details